To further our understanding of the correlation between GALT amino acid alterations and clinical manifestations of galactosemia, we performed a literature review of compound heterozygous galactosemia patients carrying the c.855G>T (p.K285N) substitution in association with other pathogenic missense variants. The gene discussed is GALT; the disease is galactosemia.